Boston deadheads its Lotus
Beset with problems from the off, the Lotus Edge aortic valve has finally been discontinued.
Moderna raises the bar for Covid-19 vaccine efficacy
The first pivotal results with Moderna’s mRNA-based Covid-19 vaccine look even better than those Biontech/Pfizer released a week ago.
A lull in FDA Covid-19 test authorisations
Just as demand for coronavirus tests is peaking, the US regulator has a quiet week.
Sumitomo takes out Urovant, and Myovant beckons
With one portfolio asset rejected by the FDA and another looking dicey, Sumitomo looks pretty reliant on Vibegron.
